, 2021. Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors. Int J Radiat Oncol Biol Phys 111(1):272-283
, 2021. Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et al. Radiother Oncol 158:244-245
, 2021. Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio. Breast Cancer 28(4):956-968
, 2021. Pilot Study to Develop and Test Palliative Care Quality Indicators for Nursing Homes. Int J Environ Res Public Health 18.
, 2020. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells. Int J Mol Sci 21.
, 2020. Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer: Post Hoc Utility of a Mean Absolute Dose Deviation Penalty Score. Technol Cancer Res Treat 19:1533033820947759
, 2020. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab. J Immunol Res 2020:2192480
, 2020. Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy. Radiother Oncol 152:111-116
, 2019. MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy. Acta Oncol 58(2):232-236
, 2019. Hypoxic Radioresistance: Can ROS Be the Key to Overcome It? Cancers (Basel) 11.
, 2019. The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease. Radiother Oncol 133:113-119
, 2019. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems. Cancer Lett 450:42-52
, 2019. Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells. Cancers (Basel) 11.
, 2019. Healthcare utilization at the end of life in people dying from amyotrophic lateral sclerosis: A retrospective cohort study using linked administrative data. J Neurol Sci 406:116444
, 2018. Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend. Front Immunol 9:2909
, 2018. Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption. Front Pharmacol 9:1073
, 2018. Targeting antioxidant enzymes as a radiosensitizing strategy. Cancer Lett 438:154-164
, 2018. Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer. Radiother Oncol 127(3):361-369
, 2018. Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI. Acta Oncol 57(6):723-727
, 2018. The long- and short-term variability of breathing induced tumor motion in lung and liver over the course of a radiotherapy treatment. Radiother Oncol 126(2):339-346
, 2017. Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma. Clin Pharmacokinet 56(8):953-961
, 2017. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species. Oncotarget 8(22):35728-35742
, 2017. Treating patients with Dynamic Wave Arc: First clinical experience. Radiother Oncol 122(3):347-351
, 2016. The cost of cancer care is not related to its outcomes. Ecancermedicalscience 10:687
, 2016. Corrigendum: Stromal contribution to the colorectal cancer transcriptome. Nat Genet 48(10):1296
, 2016. Mild Lung Restriction in Breast Cancer Patients After Hypofractionated and Conventional Radiation Therapy: A 3-Year Follow-Up. Int J Radiat Oncol Biol Phys 95(3):937-945
, 2016. Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial. Radiother Oncol 119(3):519-24
, 2016. Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc. Radiat Oncol 11:63
, 2016. Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy. Oncotarget 7(27):42698-42715
, 2016. Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion. Radiother Oncol 119(2):291-9
, 2016. Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm? Radiat Oncol 11:13
, 2016. Quality Assurance of a 50-kV Radiotherapy Unit Using EBT3 GafChromic Film: A Feasibility Study. Technol Cancer Res Treat 15(1):163-70
, 2016. Tangential IMRT versus TomoTherapy with and without breath-hold in left-sided whole breast irradiation. Acta Oncol 55(2):240-3
, 2015. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer. Oncotarget 6(14):12369-82
, 2015. Advances in radiotherapy delivery for rectal cancer: a European perspective. Expert Rev Gastroenterol Hepatol 9(4):393-7
, 2015. Stromal contribution to the colorectal cancer transcriptome. Nat Genet 47(4):312-9
, 2015. A multi-centre analysis of treatment procedures and error components in dynamic tumour tracking radiotherapy. Radiother Oncol 115(3):412-8
, 2015. Geometric Verification of Dynamic Wave Arc Delivery With the Vero System Using Orthogonal X-ray Fluoroscopic Imaging. Int J Radiat Oncol Biol Phys 92(4):754-61
, 2015. A comparison of two clinical correlation models used for real-time tumor tracking of semi-periodic motion: A focus on geometrical accuracy in lung and liver cancer patients. Radiother Oncol 115(3):419-24
, 2015. Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy. J Vis Exp.
, 2015. Feasibility of markerless tumor tracking by sequential dual-energy fluoroscopy on a clinical tumor tracking system. Radiother Oncol 117(3):487-90
, 2014. Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer. Radiother Oncol 111(1):106-9
, 2014. Advances in radiotherapy and targeted therapies for rectal cancer. World J Gastroenterol 20(1):1-5
, 2014. Feasibility of using the Vero SBRT system for intracranial SRS. J Appl Clin Med Phys 15(1):4437
, 2014. Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery. Radiat Oncol 9:36
, 2014. Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome. Radiother Oncol 110(1):155-9
, 2014. Treating patients with real-time tumor tracking using the Vero gimbaled linac system: implementation and first review. Radiother Oncol 112(3):343-51
, 2014. Fiducial marker and marker-less soft-tissue detection using fast MV fluoroscopy on a new generation EPID: investigating the influence of pulsing artifacts and artifact suppression techniques. Med Phys 41(10):101911
, 2014. Impact of inadequate respiratory motion management in SBRT for oligometastatic colorectal cancer. Radiother Oncol 113(2):235-9
, 2014. Improving the intra-fraction update efficiency of a correlation model used for internal motion estimation during real-time tumor tracking for SBRT patients: fast update or no update? Radiother Oncol 112(3):352-9
, 2014. Analysis of the targeting uncertainty of a stereotactic frameless radiosurgery technique for arteriovenous malformation. Radiother Oncol 113(3):371-3
, 2014. Breast conserving treatment for breast cancer: dosimetric comparison of sequential versus simultaneous integrated photon boost. Biomed Res Int 2014:827475
, 2013. Initial assessment of tumor tracking with a gimbaled linac system in clinical circumstances: a patient simulation study. Radiother Oncol 106(2):236-40
, 2013. Hepatocytes determine the hypoxic microenvironment and radiosensitivity of colorectal cancer cells through production of nitric oxide that targets mitochondrial respiration. Int J Radiat Oncol Biol Phys 85(3):820-7
, 2013. Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas. Radiother Oncol 106(2):192-7
, 2013. Evaluation of the clinical usefulness for using verification images during frameless radiosurgery. Radiother Oncol 108(1):114-7
, 2013. A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients. Radiat Oncol 8:206
, 2013. A complementary dual-modality verification for tumor tracking on a gimbaled linac system. Radiother Oncol 109(3):469-74
, 2013. Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers. PLoS One 8(10):e76508
, 2012. Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery. Int J Radiat Oncol Biol Phys 83(1):467-74
, 2012. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer. Int J Radiat Oncol Biol Phys 83(1):142-8
, 2012. Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer. Radiat Oncol 7:34
, 2012. Computer-aided analysis of star shot films for high-accuracy radiation therapy treatment units. Phys Med Biol 57(10):2997-3011
, 2012. Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy. World J Surg Oncol 10:86
, 2012. Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer. Front Oncol 2:47
, 2012. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies. Eur J Cancer 48(16):3045-51
, 2012. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial. Radiat Oncol 7:80
, 2012. Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer. Eur J Nucl Med Mol Imaging 39(10):1618-27
, 2012. Parotid gland sparing with helical tomotherapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys 84(2):443-8
, 2012. Implementation of HybridArc treatment technique in preoperative radiotherapy of rectal cancer: dose patterns in target lesions and organs at risk as compared to helical Tomotherapy and RapidArc. Radiat Oncol 7:120
, 2012. Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy. Breast Cancer (Auckl) 6:79-93
, 2012. Small airways function in breast cancer patients before and after radiotherapy. Breast Cancer Res Treat 135(3):857-65
, 2012. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy. BMC Cancer 12:495
, 2012. Setup accuracy of the Novalis ExacTrac 6DOF system for frameless radiosurgery. Int J Radiat Oncol Biol Phys 82(5):1627-35
, 2011. Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome. Int J Radiat Oncol Biol Phys 80(5):1338-42
, 2011. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET. Int J Radiat Oncol Biol Phys 80(1):91-6
, 2011. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys 81(4):e503-9
, 2011. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial. Int J Radiat Oncol Biol Phys 80(5):1343-9
, 2011. Delivering affordable cancer care in high-income countries. Lancet Oncol 12(10):933-80
, 2011. Geometric accuracy of a novel gimbals based radiation therapy tumor tracking system. Radiother Oncol 98(3):365-72
, 2010. Volumetric imaging by megavoltage computed tomography for assessment of internal organ motion during radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 77(5):1590-5
, 2010. Activated macrophages as a novel determinant of tumor cell radioresponse: the role of nitric oxide-mediated inhibition of cellular respiration and oxygen sparing. Int J Radiat Oncol Biol Phys 76(5):1520-7
, 2010. An in-house developed resettable MOSFET dosimeter for radiotherapy. Phys Med Biol 55(4):N97-109
, 2010. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy. Int J Radiat Oncol Biol Phys 77(5):1352-9
, 2010. Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy. Cancer 116(1):241-50
, 2009. Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC. Radiother Oncol 91(3):438-42
, 2009. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 74(5):1476-80
, 2009. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations. Surg Neurol 72(4):423-8
, 2008. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway. Bull Cancer 95(3):282-91
, 2008. Phase II study of preoperative helical tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 70(3):728-34
, 2008. A (short) history of image-guided radiotherapy. Radiother Oncol 86(1):4-13
, 2008. IFN-gamma+ CD8+ T lymphocytes: possible link between immune and radiation responses in tumor-relevant hypoxia. Int J Radiat Oncol Biol Phys 71(3):647-51
, 2008. Hypoxic tumor cell radiosensitization through nitric oxide. Nitric Oxide 19(2):164-9
, 2008. Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys 71(3):934-9
, 2008. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases. Anticancer Res 28(4C):2459-67
, 2007. Innovations in image-guided radiotherapy. Nat Rev Cancer 7(12):949-60
, 2007. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 7:164
, 2006. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase. Int J Radiat Oncol Biol Phys 66(5):1473-80
, 2005. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature. Acta Neurol Belg 105(3):137-43
, 2005. Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression. Haematologica 90(6):810-7
, 2004. Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse. Int J Radiat Oncol Biol Phys 60(2):598-606
, 2003. Metastases to the thyroid gland-a report of six cases. Eur J Intern Med 14(6):377-379
, 2003. Lipid a radiosensitizes hypoxic EMT-6 tumor cells: role of the NF-kappaB signaling pathway. Int J Radiat Oncol Biol Phys 57(3):779-86
Publication list retrieved from NCBI using ImpactPubs
.